Literature DB >> 15299285

Type II collagen peptides for measuring cartilage degradation.

Y Henrotin1, M Deberg, J-E Dubuc, E Quettier, S Christgau, J-Y Reginster.   

Abstract

This paper describes two new immunoassays for a peptide of the triple helix of type II collagen (Coll 2-1) and its nitrated form (Coll 2-1 NO(2)). In healthy subjects aged between 20 and 65 years old, Coll 2-1 and Coll 2-1 NO(2) levels in serum were in means 125.13+/-3.71 and 0.16+/-0.08 nmol/l, respectively. These levels did not significantly vary with age. However, up to 45 years of age, Coll 2-1 NO(2) levels in women were significantly higher than in men. In patients with knee osteoarthritis (OA), Coll 2-1 in serum was found to be elevated compared to healthy controls (267.45+/-26.42 nmol/l vs 126.78+/-6.61 nmol/l). Further, we have demonstrated that an increase of the urinary levels of Coll 2-1 or Coll 2-1 NO(2) over 1 year was predictive of joint space narrowing progression in OA patients. In conclusion, these preliminary results indicate that Coll 2-1 could be a predictive marker of knee OA progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15299285

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  14 in total

1.  Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.

Authors:  O Bruyere; J Collette; M Kothari; S Zaim; D White; H Genant; C Peterfy; N Burlet; D Ethgen; T Montague; C Dabrowski; J-Y Reginster
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

2.  Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing Ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy.

Authors:  J-Ph Lejeune; D Serteyn; M Gangl; N Schneider; G Deby-Dupont; M Deberg; Y Henrotin
Journal:  Vet Res Commun       Date:  2007-01-24       Impact factor: 2.459

3.  Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis.

Authors:  Denis R Verwilghen; Ann Martens; Evita Busschers; Thierry Franck; Michelle Deberg; Yves Henrotin; Laurent Vanderheyden; Didier Serteyn
Journal:  Vet Res Commun       Date:  2011-06-17       Impact factor: 2.459

4.  Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis.

Authors:  J L Huebner; J M Williams; M Deberg; Y Henrotin; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2009-10-01       Impact factor: 6.576

Review 5.  Joint and bone assessment in hand osteoarthritis.

Authors:  Roberta Ramonda; Paola Frallonardo; Estella Musacchio; Stefania Vio; Leonardo Punzi
Journal:  Clin Rheumatol       Date:  2013-10-08       Impact factor: 2.980

6.  Serological muscle loss biomarkers: an overview of current concepts and future possibilities.

Authors:  Anders Nedergaard; Morten A Karsdal; Shu Sun; Kim Henriksen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-21       Impact factor: 12.910

7.  Collagen biomarkers for arthritis applications.

Authors:  James D Birmingham; Vladimir Vilim; Virginia B Kraus
Journal:  Biomark Insights       Date:  2007-02-07

8.  Collagen catabolism through Coll2-1 and Coll2-1NO2 and myeloperoxidase activity in marathon runners.

Authors:  Yves Henrotin; Alain Labasse; Thierry Franck; Alain Bosseloir; Thierry Bury; Michelle Deberg
Journal:  Springerplus       Date:  2013-03-08

9.  Serum Levels of Coll2-1, a Specific Biomarker of Cartilage Degradation, Are Not Affected by Sampling Conditions, Circadian Rhythm, and Seasonality.

Authors:  Anne-Christine Hick; Misch Fonck; Bérénice Costes; Elisabeth Cobraiville; Sébastien Pirson; Laetitia Garcia; Alain Labasse; Steven Vander Poelen; Yves Henrotin
Journal:  Cartilage       Date:  2019-10-20       Impact factor: 3.117

10.  L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis.

Authors:  Valerio Pascale; Walter Pascale; Vito Lavanga; Valerio Sansone; Paolo Ferrario; Vito De Gennaro Colonna
Journal:  Med Sci Monit       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.